Endothelial dysfunction and cardiovascular risk in lupus nephritis: New roles for old players?-Reference-Cited by-同舟云学术

Endothelial dysfunction and cardiovascular risk in lupus nephritis: New roles for old players?

Published:2020-11-15 Issue:2 Volume:51 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur. J. Clin. Invest.

Author:

Mancardi Daniele¹^ORCID,Arrigo Elisa¹,Cozzi Martina²³,Cecchi Irene²,Radin Massimo²,Fenoglio Roberta²,Roccatello Dario²,Sciascia Savino²

Affiliation:

1. Department of Clinical and Biological Sciences University of Torino Torino Italy

2. Department of Clinical and Biological Sciences Center of Research of Immunopathology and Rare Diseases‐Nephrology and Dialysis S. Giovanni Bosco Hospital University of Turin Turin Italy

3. School of Specialization in Nephrology University of Verona Verona Italy

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13441

Reference82 articles.

1. Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis

2. A Meta-Analysis of Cardiovascular Events in Systemic Lupus Erythematosus

3. The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review

4. Cardiovascular Disease in Systemic Lupus Erythematosus: recent data on epidemiology, risk factors and prevention;Kostopoulou M;Curr Vasc Pharmacol,2019

5. The Global Burden of Ischemic Heart Disease in 1990 and 2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin in Systemic Lupus Erythematosus: Investigating Cardiovascular Impact and Nephroprotective Effects in Lupus Nephritis;ACR Open Rheumatology;2024-06-19

2. Cardiovascular risk factors and complications in patients with systemic lupus erythematosus with and without nephritis: a systematic review and meta-analysis;Lupus Science & Medicine;2024-03

3. Update of Potential Biomarkers in Risk Prediction and Monitoring of Atherosclerosis in Systemic Lupus Erythematosus to Prevent Cardiovascular Disease;Biomedicines;2023-10-17

4. Non-Traditional Pro-Inflammatory and Pro-Atherosclerotic Risk Factors Related to Systemic Lupus Erythematosus;International Journal of Molecular Sciences;2022-10-20

5. Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases;Nature Reviews Rheumatology;2022-05-04